reviewNature Reviews Clinical OncologyDec 11, 2023Closed access

The CDK4/6 inhibitor revolution — a game-changing era for breast cancer treatment

LMLaura MorrisonSLSibylle LoiblNCNicholas C. Turner

Institute of Cancer Research · Breast Cancer Now · +3 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

235
total citations
FWCI
56.43
Percentile
100%
References
216
Citations per year

Authors

3

Topics & keywords

Topics
Keywords
  • Breast cancer
  • Medicine
  • Cyclin-dependent kinase
  • Oncology
  • Disease
  • Adjuvant therapy
  • Palbociclib
  • Adjuvant
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.